Article
Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular docking
20 Jan 2023
Abstract excerpt
After the World Health Organization declared coronavirus disease 2019 (COVID-19), as a global pandemic, global health workers have been facing an unprecedented and severe challenge. Currently, a mixturetion to inhibit the exacerbation of pulmonary inflammation caused by COVID-19, Fuzheng Yugan Mixture (FZYGM), has been approved for medical institution mixturetion notification. However, the mechanism of FZYGM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
